References
bacterial vaginosis
BACTERIAL VAGINOSIS, BACTERIAL VAGINOSIS
Flow diagram illustrating the selection of participants.Effect of MED-01 on (Effect of MED-01on the vaginal symptoms evaluated by the questionnaire evaluation from baseline to 12 weeks. Change in (Effect of MED-01on vaginal lactic acid bacteria (LAB), as determined by quantitative PCR from baseline to 12 weeks after randomization of subjects. (Effect of MED-01 on vaginal BV-inducing bacteria, as determined by quantitative PCR from baseline to 12 weeks after randomization of subjects. (The Nugent scoring of Gram-stained smears for diagnosis of bacterial vaginosis.The total Nugent score is calculated as the sum of the scores for each organism group. Total score: 0–3, Normal; 4–6, Intermediate; 7–10, Bacterial vaginosis.Demographic and lifestyle characteristics of the participants at the baseline.Values are presented as mean ± standard deviation (SD); percentages may not sum to 100 because of rounding; Number of participants with bacterial vaginosis (BV) status after consuming of food supplements as determined by the Nugent scores in the MED-01 and placebo groups.Results are expressed as absolute numbers and percentages, respectively. For proportions, a chi-square two-tailed test was used.Safety assessment before and after 12 weeks of MED-01 and placebo intake.Safety assessments were performed on all participants in randomization (safety set, 